Metronidazole description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Metronidazole

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

WARNING:PRECAUTIONSINDICATIONS AND USAGE

METRONIDAZOLE DESCRIPTION


Metronidazole



CLINICAL PHARMACOLOGY









Microbiology

Trichomonas vaginalis, Entamoeba histolytica


Anaerobic Bacteria










Susceptibility Tests






INDICATIONS & USAGE

Symptomatic Trichomoniasis


Asymptomatic Trichomoniasis


Treatment of Asymptomatic Consorts


Amebiasis


Anaerobic Bacterial Infections












METRONIDAZOLE CONTRAINDICATIONS


WARNINGS

WARNINGS

Central and Peripheral Nervous System Effects


PRECAUTIONS

General




INFORMATION FOR PATIENTS

Drug Interactions


LABORATORY TESTS



DRUG INTERACTIONS







DRUG & OR LABORATORY TEST INTERACTIONS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY








PREGNANCY

Teratogenic Effects

Pregnancy Category B

Use of metronidazole for trichomoniasis during pregnancy should be restricted to those in whom alternative treatment has been inadequate. Use of metronidazole for trichomoniasis in pregnancy should be carefully evaluated because metronidazole crosses the placental barrier and its effects on the human fetal organogenesis are not known (see above).

NURSING MOTHERS



GERIATRIC USE



PEDIATRIC USE



METRONIDAZOLE ADVERSE REACTIONS













OVERDOSAGE




Treatment



DOSAGE & ADMINISTRATION



Trichomoniasis

In the Female




CONTRAINDICATIONSPRECAUTIONS, Pregnancy


In the Male


Amebiasis

Adults



Pediatric Patients


Anaerobic Bacterial Infections







HOW SUPPLIED







STORAGE AND HANDLING


PROTECT FROM LIGHT



REFERENCES




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Metronidazole

Metronidazole

Metronidazole TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-186(NDC:50111-334)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METRONIDAZOLE METRONIDAZOLE 500 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
CROSPOVIDONE
SILICON DIOXIDE
HYDROGENATED COTTONSEED OIL

Product Characteristics

Color Size Imprint Code Shape
white 16 mm PLIVA;334 BULLET

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-186-17 4 in 1 VIAL

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA070033 2011-12-15


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.